Table 2.
Group | UPIIIa in urine [ng/mg cr.] | UPIIIa in plasma [ng/ml] | p-value | |||||
---|---|---|---|---|---|---|---|---|
Mean | SD | Me | Mean | SD | Me | in urine | in plasma | |
C | 1.02 | 0.54 | 0.98 | 0.58 | 0.31 | 0.65 | p≤0.001 | p≤0.001 |
BC | 2.44 | 1.41 | 2.11 | 1.47 | 0.76 | 1.32 | BC vs C | BC vs C |
| ||||||||
NMIBC | 2.38 | 1.36 | 2.10 | 1.37 | 0.56 | 1.25 | p=0.5978 | p=0.4312 |
MIBC | 2.64 | 1.59 | 2.23 | 1.77 | 1.15 | 1.32 | NMIBC vs MIBC | NMIBC vs MIBC |
| ||||||||
LG | 2.44 | 1.37 | 2.11 | 1.42 | 0.62 | 1.32 | p≤0.001 | p≤0.001 |
LG vs C | LG vs C | |||||||
HG | p=0≤0.001 | p≤0.001 | ||||||
2.44 | 1.48 | 2.21 | 1.52 | 0.90 | 1.22 | HG vs C | HG vs C | |
p=0.9945 | p=0.9939 | |||||||
LG vs HG | LG vs HG | |||||||
| ||||||||
Non-smoking BC | 2.02 | 1.11 | 2.02 | 0.96 | 0.61 | 0.96 | p> 0.05 | p> 0.05 |
Smoking BC | 2.11 | 1.48 | 2.11 | 1.32 | 0.81 | 1.32 | non-smoking BC | non-smoking BC |
vs smoking BC | vs smoking BC | |||||||
| ||||||||
Non-smoking C | 1.28 | 0.41 | 1.17 | 0.68 | 0.33 | 0.69 | p>0.05 | p>0.05 |
Smoking C | 0.94 | 0.56 | 0.91 | 0.553 | 0.30 | 0.65 | non-smoking C | non-smoking C |
vs smoking C | vs smoking C |
UPIIIa: uroplakin IIIa; C: control group; BC: patient group; NMIBC: nonmuscle invasive BC; MIBC: muscle invasive BC; LG: low grade; HG: high grade; SD: standard deviation; p: statistically significant difference; Me: median